Drug Repositioning (eBook, ePUB)
Approaches and Applications for Neurotherapeutics
Redaktion: Dudley, Joel; Berliocchi, Laura
Schade – dieser Artikel ist leider ausverkauft. Sobald wir wissen, ob und wann der Artikel wieder verfügbar ist, informieren wir Sie an dieser Stelle.
Drug Repositioning (eBook, ePUB)
Approaches and Applications for Neurotherapeutics
Redaktion: Dudley, Joel; Berliocchi, Laura
- Format: ePub
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei
bücher.de, um das eBook-Abo tolino select nutzen zu können.
Hier können Sie sich einloggen
Hier können Sie sich einloggen
Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
Drug Repositioning: Approaches and Applications for Neurotherapeutics reviews history and advances in drug repositioning, with a special focus on therapeutics for nervous system diseases.
- Geräte: eReader
- mit Kopierschutz
- eBook Hilfe
- Größe: 6.34MB
Drug Repositioning: Approaches and Applications for Neurotherapeutics reviews history and advances in drug repositioning, with a special focus on therapeutics for nervous system diseases.
Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: Taylor & Francis
- Seitenzahl: 329
- Erscheinungstermin: 14. Juli 2017
- Englisch
- ISBN-13: 9781315356211
- Artikelnr.: 48804913
- Verlag: Taylor & Francis
- Seitenzahl: 329
- Erscheinungstermin: 14. Juli 2017
- Englisch
- ISBN-13: 9781315356211
- Artikelnr.: 48804913
Dr. Joel Dudley is associate professor of genetics and genomic sciences and director of biomedical informatics at Mount Sinai School of Medicine, New York (NY, USA). Dr. Laura Berliocchi is associate professor of pharmacology at the Department of Health Sciences, Magna Graecia University (Catanzaro, Italy).
Section I The Rationale and Economics
of Drug Repositioning
Chapter 1 Scientific and Commercial Value of Drug Repurposing
David Cavalla
Chapter 2 Repurposing for Alzheimer's and Parkinson's Diseases: The
Ideas, the Pipeline, the Successes, and the Disappointments
Hermann Mucke
Chapter 3 Contribution of Not-for-Profit Organizations to Drug Repurposing
Bruce Bloom
Section II Repositioning Approaches and
Technologies: From Serendipity to
Systematic and Rational Strategies
Chapter 4 Systematic Drug Repositioning
Spyros N. Deftereos, Aris Persidis, Andreas Persidis,
Eftychia Lekka, Christos Andronis, and Vassilis Virvillis
Chapter 5 Technical Tools for Computational Drug Repositioning
Francesco Napolitano
Chapter 6 RNAi Screening toward Therapeutic Drug Repurposing
Nichole Orr-Burks, Byoung-Shik Shim, Olivia Perwitasari,
and Ralph A. Tripp
Chapter 7 Phenotypic Screening
Christine M. Macolino-Kane, John R. Ciallella,
Christopher A. Lipinski, and Andrew G. Reaume
Section III Drug Repositioning for
Nervous System Diseases
Chapter 8 A Case Study: Chlorpromazine
Francisco López-Munoz, Cecilio Álamo,
and Silvia E. García-Ramos
Chapter 9 Drug Repurposing for Central Nervous System Disorders: A
Pillar of New Drug Discovery
Mondher Toumi, Aleksandra Caban, Anna Kapüniak,
Szymon Jaros¿awski, and Cecile Rémuzat
Chapter 10 Repurposing Opportunities for Parkinson's Disease Therapies
Giulia Ambrosi, Silvia Cerri, and Fabio Blandini
Chapter 11 Drug Candidates for Repositioning in Alzheimer's Disease
Maria P. del Castillo-Frias and Andrew J. Doig
Chapter 12 Promising Candidates for Drug Repurposing in Huntington's
Disease
Francesca Romana Fusco and Emanuela Paldino
Chapter 13 Drug Repositioning Opportunities in Psychiatry
Alexander W. Charney, Joseph R. Scarpa, Douglas M. Ruderfer,
and Dennis S. Charney
Chapter 14 Pharmacology of Amyotrophic Lateral Sclerosis: Old Strategies
and New Perspectives
Tiziana Petrozziello, Valentina Tedeschi, Alba Esposito,
and Agnese Secondo
Chapter 15 Repositioning Clinic-Ready Compounds for the Treatment
of Spinal Muscular Atrophy
Faraz Farooq
Chapter 16 Rescuing Ischemic Brain Injury by Targeting the Immune
Response through Repositioned Drugs
Diana Amantea and Giacinto Bagetta
of Drug Repositioning
Chapter 1 Scientific and Commercial Value of Drug Repurposing
David Cavalla
Chapter 2 Repurposing for Alzheimer's and Parkinson's Diseases: The
Ideas, the Pipeline, the Successes, and the Disappointments
Hermann Mucke
Chapter 3 Contribution of Not-for-Profit Organizations to Drug Repurposing
Bruce Bloom
Section II Repositioning Approaches and
Technologies: From Serendipity to
Systematic and Rational Strategies
Chapter 4 Systematic Drug Repositioning
Spyros N. Deftereos, Aris Persidis, Andreas Persidis,
Eftychia Lekka, Christos Andronis, and Vassilis Virvillis
Chapter 5 Technical Tools for Computational Drug Repositioning
Francesco Napolitano
Chapter 6 RNAi Screening toward Therapeutic Drug Repurposing
Nichole Orr-Burks, Byoung-Shik Shim, Olivia Perwitasari,
and Ralph A. Tripp
Chapter 7 Phenotypic Screening
Christine M. Macolino-Kane, John R. Ciallella,
Christopher A. Lipinski, and Andrew G. Reaume
Section III Drug Repositioning for
Nervous System Diseases
Chapter 8 A Case Study: Chlorpromazine
Francisco López-Munoz, Cecilio Álamo,
and Silvia E. García-Ramos
Chapter 9 Drug Repurposing for Central Nervous System Disorders: A
Pillar of New Drug Discovery
Mondher Toumi, Aleksandra Caban, Anna Kapüniak,
Szymon Jaros¿awski, and Cecile Rémuzat
Chapter 10 Repurposing Opportunities for Parkinson's Disease Therapies
Giulia Ambrosi, Silvia Cerri, and Fabio Blandini
Chapter 11 Drug Candidates for Repositioning in Alzheimer's Disease
Maria P. del Castillo-Frias and Andrew J. Doig
Chapter 12 Promising Candidates for Drug Repurposing in Huntington's
Disease
Francesca Romana Fusco and Emanuela Paldino
Chapter 13 Drug Repositioning Opportunities in Psychiatry
Alexander W. Charney, Joseph R. Scarpa, Douglas M. Ruderfer,
and Dennis S. Charney
Chapter 14 Pharmacology of Amyotrophic Lateral Sclerosis: Old Strategies
and New Perspectives
Tiziana Petrozziello, Valentina Tedeschi, Alba Esposito,
and Agnese Secondo
Chapter 15 Repositioning Clinic-Ready Compounds for the Treatment
of Spinal Muscular Atrophy
Faraz Farooq
Chapter 16 Rescuing Ischemic Brain Injury by Targeting the Immune
Response through Repositioned Drugs
Diana Amantea and Giacinto Bagetta
Section I The Rationale and Economics
of Drug Repositioning
Chapter 1 Scientific and Commercial Value of Drug Repurposing
David Cavalla
Chapter 2 Repurposing for Alzheimer's and Parkinson's Diseases: The
Ideas, the Pipeline, the Successes, and the Disappointments
Hermann Mucke
Chapter 3 Contribution of Not-for-Profit Organizations to Drug Repurposing
Bruce Bloom
Section II Repositioning Approaches and
Technologies: From Serendipity to
Systematic and Rational Strategies
Chapter 4 Systematic Drug Repositioning
Spyros N. Deftereos, Aris Persidis, Andreas Persidis,
Eftychia Lekka, Christos Andronis, and Vassilis Virvillis
Chapter 5 Technical Tools for Computational Drug Repositioning
Francesco Napolitano
Chapter 6 RNAi Screening toward Therapeutic Drug Repurposing
Nichole Orr-Burks, Byoung-Shik Shim, Olivia Perwitasari,
and Ralph A. Tripp
Chapter 7 Phenotypic Screening
Christine M. Macolino-Kane, John R. Ciallella,
Christopher A. Lipinski, and Andrew G. Reaume
Section III Drug Repositioning for
Nervous System Diseases
Chapter 8 A Case Study: Chlorpromazine
Francisco López-Munoz, Cecilio Álamo,
and Silvia E. García-Ramos
Chapter 9 Drug Repurposing for Central Nervous System Disorders: A
Pillar of New Drug Discovery
Mondher Toumi, Aleksandra Caban, Anna Kapüniak,
Szymon Jaros¿awski, and Cecile Rémuzat
Chapter 10 Repurposing Opportunities for Parkinson's Disease Therapies
Giulia Ambrosi, Silvia Cerri, and Fabio Blandini
Chapter 11 Drug Candidates for Repositioning in Alzheimer's Disease
Maria P. del Castillo-Frias and Andrew J. Doig
Chapter 12 Promising Candidates for Drug Repurposing in Huntington's
Disease
Francesca Romana Fusco and Emanuela Paldino
Chapter 13 Drug Repositioning Opportunities in Psychiatry
Alexander W. Charney, Joseph R. Scarpa, Douglas M. Ruderfer,
and Dennis S. Charney
Chapter 14 Pharmacology of Amyotrophic Lateral Sclerosis: Old Strategies
and New Perspectives
Tiziana Petrozziello, Valentina Tedeschi, Alba Esposito,
and Agnese Secondo
Chapter 15 Repositioning Clinic-Ready Compounds for the Treatment
of Spinal Muscular Atrophy
Faraz Farooq
Chapter 16 Rescuing Ischemic Brain Injury by Targeting the Immune
Response through Repositioned Drugs
Diana Amantea and Giacinto Bagetta
of Drug Repositioning
Chapter 1 Scientific and Commercial Value of Drug Repurposing
David Cavalla
Chapter 2 Repurposing for Alzheimer's and Parkinson's Diseases: The
Ideas, the Pipeline, the Successes, and the Disappointments
Hermann Mucke
Chapter 3 Contribution of Not-for-Profit Organizations to Drug Repurposing
Bruce Bloom
Section II Repositioning Approaches and
Technologies: From Serendipity to
Systematic and Rational Strategies
Chapter 4 Systematic Drug Repositioning
Spyros N. Deftereos, Aris Persidis, Andreas Persidis,
Eftychia Lekka, Christos Andronis, and Vassilis Virvillis
Chapter 5 Technical Tools for Computational Drug Repositioning
Francesco Napolitano
Chapter 6 RNAi Screening toward Therapeutic Drug Repurposing
Nichole Orr-Burks, Byoung-Shik Shim, Olivia Perwitasari,
and Ralph A. Tripp
Chapter 7 Phenotypic Screening
Christine M. Macolino-Kane, John R. Ciallella,
Christopher A. Lipinski, and Andrew G. Reaume
Section III Drug Repositioning for
Nervous System Diseases
Chapter 8 A Case Study: Chlorpromazine
Francisco López-Munoz, Cecilio Álamo,
and Silvia E. García-Ramos
Chapter 9 Drug Repurposing for Central Nervous System Disorders: A
Pillar of New Drug Discovery
Mondher Toumi, Aleksandra Caban, Anna Kapüniak,
Szymon Jaros¿awski, and Cecile Rémuzat
Chapter 10 Repurposing Opportunities for Parkinson's Disease Therapies
Giulia Ambrosi, Silvia Cerri, and Fabio Blandini
Chapter 11 Drug Candidates for Repositioning in Alzheimer's Disease
Maria P. del Castillo-Frias and Andrew J. Doig
Chapter 12 Promising Candidates for Drug Repurposing in Huntington's
Disease
Francesca Romana Fusco and Emanuela Paldino
Chapter 13 Drug Repositioning Opportunities in Psychiatry
Alexander W. Charney, Joseph R. Scarpa, Douglas M. Ruderfer,
and Dennis S. Charney
Chapter 14 Pharmacology of Amyotrophic Lateral Sclerosis: Old Strategies
and New Perspectives
Tiziana Petrozziello, Valentina Tedeschi, Alba Esposito,
and Agnese Secondo
Chapter 15 Repositioning Clinic-Ready Compounds for the Treatment
of Spinal Muscular Atrophy
Faraz Farooq
Chapter 16 Rescuing Ischemic Brain Injury by Targeting the Immune
Response through Repositioned Drugs
Diana Amantea and Giacinto Bagetta